HOME >> BIOLOGY >> NEWS
American Cancer Society funds Space Station scientist who studies how good cells turn bad

Every second, your body's cells get instructions on what they are supposed to do from DNA -- the double-helix strand of deoxyribonucleic acid that is the genetic ingredient essential for life.

In healthy cells, proteins manufacture DNA and remove or repair any broken strands. When proteins fail to repair damaged DNA, good cells may turn bad, resulting in a plethora of diseases, including cancer.

Yearly mammograms and daily inspections for lumps make women intimately aware that bad cells form tumors. According to the America Cancer Society, in 2001 almost 200,000 women were diagnosed with new cases of breast cancer -- and some 40,000 women were killed by the disease.

To understand how these basic molecular processes cause breast cancer, the American Cancer Society has awarded a $768,000, four-year grant to Dr. Gloria Borgstahl, a biochemist at the University of Toledo in Ohio. Borgstahl's grant proposal to the American Cancer Society was rated first of 57 submissions to the Genetic Mechanisms in Cancer grant selection committee.

"I am not discovering a cure for cancer," cautioned Borgstahl, "but the American Cancer Society and NASA recognize that understanding basic molecular processes in the body will ultimately provide the knowledge researchers need to get closer to that cure."

Right now, Borgstahl is doing related experiments on the International Space Station. She is in her first year of research funded by a three-year, $830,000-grant awarded by NASA's Office of Biological and Physical Research as part of the Macromolecular Biotechnology Program at NASA's Marshall Space Flight Center in Huntsville, Ala.

On April 19, the Space Shuttle Atlantis returned with the first biological crystals that she grew on the Space Station.

The American Cancer Society funding will help Borgstahl study Replication Protein A, know as RPA, and another protein called Rad52. Scientists discovered RPA and learned
'"/>

Contact: Steve Roy
steve.roy@msfc.nasa.gov
256-544-0034
NASA/Marshall Space Flight Center News Center
2-May-2002


Page: 1 2 3 4

Related biology news :

1. Highlights of the October 2004 Journal of the American Dietetic Association
2. The American Phytopathological Society announces 2004 awards
3. Tips from the Journals of the American Society for Microbiology
4. Highlights of American Chemical Society national meeting in Philadelphia, Aug. 22-26
5. NIH roadmap for biomedical research focus of chemists at American Chemical Society meeting
6. Tips from the journals of the American Society for Microbiology
7. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
8. More aggressive breast cancer tumors found in African American women
9. American Society of Mammalogists honors CI president Russell Mittermeier with Aldo Leopold award
10. Tips from the Journals of the American Society for Microbiology
11. Most Americans not sure about the sources of high cholesterol

Post Your Comments:
(Date:5/23/2013)... Rollins School of Public Health at Emory University, ... Technology, have received a $4 million grant over ... Emory University (Health and Exposome Research Center: Understanding ... center grant awarded in the United States. ... National Institute of Environmental Health Sciences (NIEHS) of ...
(Date:5/23/2013)... for the overall health, development, and academic success ... in ensuring that all students have opportunities to ... of vigorous or moderate-intensity physical activity, says a ... Recent estimates suggest that only about half of ... better health and development. The report recommends ...
(Date:5/23/2013)... treating cerebral palsy with autologous cord blood. Following a ... old boy had been in a persistent vegetative state ... after treatment with the cord blood containing stem cells, ... child learned to speak simple sentences and to move. ... dispel the long-held doubts about the effectiveness of the ...
Breaking Biology News(10 mins):Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3Schools should provide opportunities for 60 minutes of daily physical activity to all students 2Schools should provide opportunities for 60 minutes of daily physical activity to all students 3First successful treatment of pediatric cerebral palsy with autologous cord blood 2
(Date:5/24/2013)... BOSTON and TEL AVIV, Israel ... ("InspireMD" or the "Company") (NYSE MKT: NSPR), a leader in ... , the Company,s President and Chief Executive Officer, and ... will participate in the Benchmark Company, LLC One-on-One Investor Conference ... East Wisconsin Ave., Milwaukee, WI. ...
(Date:5/24/2013)... May 24, 2013 Many factors impact ... uptake or efflux transporters at the blood-tissue barrier. Even ... to unbound fractions in the tissue rather than the ... disposition challenges is required to guide lead optimization, predict ... any species-dependent variables that may impact the likely human ...
(Date:5/24/2013)... 2013 Quincy Bioscience, a leading ... of calcium-binding proteins to support healthy living, is ... study of apoaequorin in Food and ... the British Industrial Biological Research Association. , ... potential adverse effects, if any, of apoaequorin, in ...
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
Breaking Biology Technology:InspireMD To Participate In Benchmark Investor Conference On May 30th 2InspireMD To Participate In Benchmark Investor Conference On May 30th 3InspireMD To Participate In Benchmark Investor Conference On May 30th 4DMPK for Targeted Tissue Delivery: Solutions for the Most Challenging Part of Outsourcing, New Life Science Webinar Hosted by Xtalks 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3
Cached News: